Literature DB >> 19772491

Kukoamine A analogs with lipoxygenase inhibitory activity.

Dimitra Hadjipavlou-Litina1, Thomas Garnelis, Constantinos M Athanassopoulos, Dionissios Papaioannou.   

Abstract

Kukoamine A (KukA) is a spermine (SPM) conjugate with dihydrocaffeic acid (DHCA), with interesting biological activities. The four possible regioisomers of KukA, as well as a series of KukA analogs incorporating changes in either the SPM or the DHCA structural units, were evaluated for their antioxidant activity and their inhibitory activity on soybean lipoxygenase (LOX) and lipid peroxidation. The reducing properties of the compounds were evaluated using the 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical scavenging assay and found to be in the range 5-97.5%. KukA significantly inhibits LOX with IC(50) 9.5 microM. All tested analogs inhibited lipid peroxidation in the range of 11-100%. The most potent compounds KukA and its analog 3, in which the DHCA units had been replaced by O,O9-dimethylcaffeic acid units, were studied for their anti-inflammatory activity in vivo on rat paw edema induced by carrageenan and found to be of comparable activity to indomethacin. The results of the biological tests are discussed in terms of structural characteristics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19772491     DOI: 10.1080/14756360902779193

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  10 in total

1.  Neuroprotective Effects of Kukoamine a against Radiation-induced Rat Brain Injury through Inhibition of Oxidative Stress and Neuronal Apoptosis.

Authors:  Yaqiong Zhang; Zhihua Cheng; Changli Wang; Hongda Ma; Weihong Meng; Qingchun Zhao
Journal:  Neurochem Res       Date:  2016-05-30       Impact factor: 3.996

2.  Kukoamine A Prevents Radiation-Induced Neuroinflammation and Preserves Hippocampal Neurogenesis in Rats by Inhibiting Activation of NF-κB and AP-1.

Authors:  Yaqiong Zhang; Lingyue Gao; Zhihua Cheng; Jiayi Cai; Yixuan Niu; Weihong Meng; Qingchun Zhao
Journal:  Neurotox Res       Date:  2016-11-04       Impact factor: 3.911

3.  The Prophylactic and Multimodal Activity of Two Isatin Thiosemicarbazones against Alzheimer's Disease In Vitro.

Authors:  Barbara Mavroidi; Archontia Kaminari; Dimitris Matiadis; Dimitra Hadjipavlou-Litina; Maria Pelecanou; Athina Tzinia; Marina Sagnou
Journal:  Brain Sci       Date:  2022-06-19

4.  Exploiting members of the BAHD acyltransferase family to synthesize multiple hydroxycinnamate and benzoate conjugates in yeast.

Authors:  Aymerick Eudes; Maxence Mouille; David S Robinson; Veronica T Benites; George Wang; Lucien Roux; Yi-Lin Tsai; Edward E K Baidoo; Tsan-Yu Chiu; Joshua L Heazlewood; Henrik V Scheller; Aindrila Mukhopadhyay; Jay D Keasling; Samuel Deutsch; Dominique Loqué
Journal:  Microb Cell Fact       Date:  2016-11-21       Impact factor: 5.328

5.  Kukoamine A activates Akt/GSK-3β signaling pathway to inhibit oxidative stress and relieve myocardial ischemia-reperfusion injury.

Authors:  Han Xu; Guibin Zhang; Long Deng
Journal:  Acta Cir Bras       Date:  2022-07-22       Impact factor: 1.564

6.  Solving the jigsaw puzzle of wound-healing potato cultivars: metabolite profiling and antioxidant activity of polar extracts.

Authors:  Keyvan Dastmalchi; Qing Cai; Kevin Zhou; Wenlin Huang; Olga Serra; Ruth E Stark
Journal:  J Agric Food Chem       Date:  2014-07-23       Impact factor: 5.279

7.  Kukoamine A inhibits human glioblastoma cell growth and migration through apoptosis induction and epithelial-mesenchymal transition attenuation.

Authors:  Qiaoping Wang; Haiyan Li; Zhen Sun; Lihua Dong; Ling Gao; Chunlan Liu; Xiujie Wang
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

8.  Antioxidant and Cytoprotective Effects of Kukoamines A and B: Comparison and Positional Isomeric Effect.

Authors:  Xican Li; Jian Lin; Ban Chen; Hong Xie; Dongfeng Chen
Journal:  Molecules       Date:  2018-04-21       Impact factor: 4.411

9.  Meta-Analysis on the Chinese Herbal Formula Xiaoer-Feike Granules as a Complementary Therapy for Children With Acute Lower Respiratory Infections.

Authors:  Qiang You; Lan Li; Dan Li; Dan Yang; Lin Chen; Hong-Ping Chen; You-Ping Liu
Journal:  Front Pharmacol       Date:  2020-10-22       Impact factor: 5.810

10.  Exploring the 2'-Hydroxy-Chalcone Framework for the Development of Dual Antioxidant and Soybean Lipoxygenase Inhibitory Agents.

Authors:  Ioanna Kostopoulou; Andromachi Tzani; Nestor-Ioannis Polyzos; Maria-Anna Karadendrou; Eftichia Kritsi; Eleni Pontiki; Thalia Liargkova; Dimitra Hadjipavlou-Litina; Panagiotis Zoumpoulakis; Anastasia Detsi
Journal:  Molecules       Date:  2021-05-08       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.